Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
Octreotide Acetate, a synthetic analogue of the naturally occurring hormone somatostatin, plays a pivotal role in modern endocrine therapies due to its specific mechanism of action. By mimicking somatostatin's inhibitory effects on hormone secretion, it provides a therapeutic avenue for conditions characterized by hormonal overproduction. NINGBO INNO PHARMCHEM CO.,LTD. is a significant producer of this vital pharmaceutical intermediate, contributing to advancements in medical treatments.
The core of Octreotide Acetate's efficacy lies in its ability to bind with high affinity to somatostatin receptors (SSTRs) distributed throughout the body, particularly in the pituitary gland, pancreas, and gastrointestinal tract. Upon binding, it triggers a cascade of intracellular events that lead to the suppression of hormone release. This targeted action is what makes it invaluable for treating specific endocrine disorders.
One of the primary applications is in acromegaly, where it significantly reduces the hypersecretion of growth hormone (GH) from pituitary adenomas. By inhibiting GH release, Octreotide Acetate helps to normalize insulin-like growth factor 1 (IGF-1) levels, thereby alleviating the symptoms and progression of acromegaly. The detailed octreotide acetate mechanism of action in this context highlights its therapeutic precision.
Octreotide Acetate also demonstrates potent inhibitory effects on other hormones, including insulin, glucagon, gastrin, and vasoactive intestinal peptide (VIP). This broad-spectrum inhibition is beneficial in managing conditions like insulinomas, where excess insulin secretion can lead to hypoglycemia, and in treating symptoms associated with certain neuroendocrine tumors, such as carcinoid syndrome and VIPomas. The understanding of octreotide acetate uses is intrinsically linked to its multi-faceted hormonal control.
The octreotide acetate manufacturing process is engineered to produce a molecule with enhanced stability and a longer duration of action compared to native somatostatin. This characteristic ensures sustained therapeutic effects, reducing the frequency of administration. NINGBO INNO PHARMCHEM CO.,LTD. ensures that this precision in synthesis translates to high-quality Octreotide Acetate, making them a trusted source among octreotide acetate suppliers. For inquiries about octreotide acetate CAS 83150-76-9, NINGBO INNO PHARMCHEM CO.,LTD. provides reliable solutions.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
